AI assistant
AIM ImmunoTech Inc. — Share Issue/Capital Change 2026
Jan 21, 2026
35334_rns_2026-01-21_ce5d06be-5a9a-4e53-aa79-32abf7c9e6a4.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 6398P
AIM
21 January 2026
NOTICE
21/01/2026 - 08:00
The London Stock Exchange admits the following securities to trading on AIM:
| Agronomics Limited | ||
| 10,026,375 | ORDINARY SHARES OF 0.0001P EACH FULLY PAID | (B6QH1J2)(IM00B6QH1J21) |
| CAPITAL METALS PLC | ||
| 146,550 | ORDINARY SHARES OF 0.2P EACH, FULLY PAID | (BMF7560)(GB00BMF75608) |
| GCM Resources Plc | ||
| 16,666,667 | ORDINARY SHARES OF 1P EACH, FULLY PAID | (B00KV28)(GB00B00KV284) |
| NIOX Group plc | Block Admission | |
| 165,413 | ORDINARY SHARES OF 0.08P; FULLY PAID | (BJVD3B2)(GB00BJVD3B28) |
| Pulsar Helium Inc. | ||
| 6,300 | COMMON SHARES OF NO PAR VALUE, FULLY PAID (DI) | (BS0CZX9)(CA7459321039) |
| Rockhopper Exploration Plc | ||
| 13,188,036 | ORDINARY SHARES OF 1P EACH, FULLY PAID | (B0FVQX2)(GB00B0FVQX23) |
If you have any queries or require further information, please contact Market Operations on 020 7797 4310.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AMOBSGDBLDDDGLG